Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Yee

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Cancer Research|December 20, 2018
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast CancerIkbale El Ayachi, Iram Fatima, Peter Wend, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Environmental Science & Technology|August 24, 2016
Ambient Gas-Particle Partitioning of Tracers for Biogenic OxidationGabriel Isaacman-VanWertz, Lindsay D Yee, Nathan M Kreisberg, et al.
Environmental Science & Technology|April 10, 2020
Natural and Anthropogenically Influenced Isoprene Oxidation in Southeastern United States and Central AmazonLindsay D Yee, Gabriel Isaacman-VanWertz, Rebecca A Wernis, et al.
Nature Communications|July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapyGina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
Nature Cell Biology|December 20, 2011
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320A Bronisz, J Godlewski, J A Wallace, et al.
Immunotherapy|June 18, 2025
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summaryShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Cancer Prevention Research (Philadelphia, Pa.)|April 22, 2020
Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast CancerCarol J Fabian, Seema A Khan, Judy E Garber, et al.
Cancer Research|December 20, 2018
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast CancerIkbale El Ayachi, Iram Fatima, Peter Wend, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Environmental Science & Technology|August 24, 2016
Ambient Gas-Particle Partitioning of Tracers for Biogenic OxidationGabriel Isaacman-VanWertz, Lindsay D Yee, Nathan M Kreisberg, et al.
Environmental Science & Technology|April 10, 2020
Natural and Anthropogenically Influenced Isoprene Oxidation in Southeastern United States and Central AmazonLindsay D Yee, Gabriel Isaacman-VanWertz, Rebecca A Wernis, et al.
Nature Communications|July 19, 2018
Stromal PTEN determines mammary epithelial response to radiotherapyGina M Sizemore, Subhasree Balakrishnan, Katie A Thies, et al.
Nature Cell Biology|December 20, 2011
Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320A Bronisz, J Godlewski, J A Wallace, et al.
Immunotherapy|June 18, 2025
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summaryShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2021
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapyL Du, C Yau, L Brown-Swigart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 9, 2024
Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review StudyShanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, et al.
Pageof 38